_________________________________________
FREE Daily Stock Alerts From DrStockPick.com
_________________________________________
DrStockPick.com Watch List!
My Picks for Monday Jan. 25, 2010 are:
PARD, Poniard Pharmaceuticals, Inc.
PARD is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer.
PARD’s picoplatin is a new generation platinum chemotherapy agent with the potential to become a platform product addressing multiple indications, combinations and formulations. Picoplatin has an improved safety profile compared to existing platinum-based chemotherapeutics. It was designed to overcome platinum resistance associated with chemotherapy in solid tumors and delay time to relapse.
According to final data from a randomized, controlled Phase 2 trial of picoplatin in metastatic colorectal cancer (CRC) patients, PARD’s picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI regimen) was associated with a statistically significant reduction in neurotoxicity (p <0.004) compared to oxaliplatin given in combination with 5-fluorouracil and leucovorin (FOLFOX regimen).
In other words, PARD reported that study data to date suggest that picoplatin has an improved safety profile relative to existing platinum-based cancer therapies and can be safely administered in combination with multiple approved oncology products. Approximately 1,100 patients have received picoplatin. Results obtained to date suggest that hematologic events are common but manageable. Kidney toxicity (nephrotoxicity) and nerve toxicity (neurotoxicity) are less frequent and less severe than is commonly observed with other platinum chemotherapy drugs. Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors.
More about PARD at www.poniard.com
PMDP, Plateau Mineral Development, Inc., PMDP.PK
Of all the waste products known, the most expensive is a truck tire. In the United States alone, 300 million tires are thrown away each year. These castoffs are a huge source of automotive-related pollution; the average used tire weighs 22.5 pounds and contains about two gallons of fuel, as well as other combustible carbon compounds. Dumped into huge stockpiles, tires can feed huge fires and contribute to the spread of disease by harboring vermin and serving as mosquito breeding grounds. The purpose of PMDP’s converter project is to produce an operational production unit that demonstrates the cost-effectiveness of the improved technology needed to reclaim trash items and organize associated environmental clean up at a profit.
PMDP’s converter unit has been designed to process six tons of scrap tires per day. Based on that figure, the project will begin yielding profit during the first year, and is expected to generate approximately $2,252,838 in revenue annually thereafter (Natural gas and carbon black have the potential to generate $140,000 and $236,133 in the first year, respectively, but the majority of the revenue is expected to come from sales of the solvent which is projected to be around $2,300,000 in the first year).
Just check this out:
The catalyzing end product of PMDP’s tire converter system, the Dilution Solvent, will be used to treat existing oil wells to liberate oil that is too viscous (thick) to economically be pumped from the wells.
The ratio for dilution of the PMDP’s Dilution Solvent is at about 50:1; or about one gallon (or a little less dependent on the viscosity of the “in ground oil”) of solvent used for one barrel of oil pumped.
Once the PMDP’s Dilution Solvent is used to “thin” the oil, the oil can be pumped and sold, generating new incremental revenues for the pumping company.
Use of the PMDP’s Dilution Solvent in the oil field will facilitate the economic production of oil that was previously uneconomic to produce. It’s more profitable for operators to use oil from its existing wells than to risk drilling new wells. In short, the wells have been drilled and are simply waiting for the solvent to liberate the oil so it can be pumped into tanks and sold at market.
One barrel (42.2 gallons) of PMDP’s Dilution Solvent at a cost of $25.00 per gallon will sell for approximately $1,000.
That’s a HUGE Market opportunity for PMDP. Just take a look at PMDP’s 1 month chart:
More about PMDP at www.plateaumineral.net
Picoplatin is a new generation organic platinum analog with an extended spectrum of antineoplastic activity. Designed to overcome platinum drug resistance, picoplatin alkylates DNA, forming both inter- and intra-strand cross-linkages, Picoplatin
ReplyDelete